Life Sciences Blade Therapeutics Announces Feedback from FDA on End-of-Phase 1 Data Package AIT News Desk Apr 4, 2022 U.S. Food and Drug Administration (FDA) provides feedback necessary to proceed into a phase 2 proof of concept (PoC)/dose ranging study of…